Cargando…
ALW-II-41-27, an EphA2 inhibitor, inhibits proliferation, migration and invasion of cervical cancer cells via inhibition of the RhoA/ROCK pathway
Recent studies have shown that the Eph receptor A2 (EphA2) and its inhibitor ALW-II-41-27 could regulate various cellular processes in several types of cancer. However, the manner in which ALW-II-41-27 affects the development of cervical cancer (CC) remains unknown. The present study aimed to evalua...
Autores principales: | Li, Xiang, Li, Dan, Ma, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895465/ https://www.ncbi.nlm.nih.gov/pubmed/35251349 http://dx.doi.org/10.3892/ol.2022.13249 |
Ejemplares similares
-
A TRANSCRIPTIONAL CROSS–TALK BETWEEN RhoA AND c–Myc INHIBITS THE RhoA/Rock–DEPENDENT CYTOSKELETON
por: Sauzeau, Vincent, et al.
Publicado: (2010) -
Axon growth inhibition by RhoA/ROCK in the central nervous system
por: Fujita, Yuki, et al.
Publicado: (2014) -
Brusatol Inhibits Proliferation and Metastasis of Colorectal Cancer by Targeting and Reversing the RhoA/ROCK1 Pathway
por: Lu, Rui-jin, et al.
Publicado: (2022) -
EphA receptors regulate prostate cancer cell dissemination through Vav2–RhoA mediated cell–cell repulsion
por: Batson, Jennifer, et al.
Publicado: (2014) -
Valsartan inhibits RhoA-ROCK2-MYL pathway in rat model of alcoholic cardiomyopathy
por: Li, Luyifei, et al.
Publicado: (2019)